<DOC>
	<DOCNO>NCT00425230</DOCNO>
	<brief_summary>This study ass possible benefit duloxetine treatment chronic phantom limb pain .</brief_summary>
	<brief_title>Open Label Study Duloxetine Treatment Phantom Limb Pain</brief_title>
	<detailed_description />
	<mesh_term>Phantom Limb</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>1 . Chronic PLP &gt; 6 month 2 . ShortForm McGill Pain Questionnaire Sensory Pain Rating Index raw score ≥ 16 3 . Age ≥ 18 year old 4 . Inpatient Outpatient 5 . Able come appointment , opinion investigator 6 . Able give inform consent , opinion investigator 1 . Current Major Depressive disorder , Anxiety Disorder , Psychotic disorder assess Mini International Neuropsychiatric Interview ( MINI ) 2 . Substance abuse dependence within last six month , assess MINI 3 . Known Diabetes Mellitus exclude diabetic peripheral neuropathy 4 . History coronary artery disease , hepatic disease , renal disease 5 . Other pain syndrome 6 . Any unstable medical condition opinion investigator 7 . Other psychotropic medication exclude hypnotic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
</DOC>